Back
MaxLinear, Inc. 10K Form
Sell
34
MXL
MaxLinear, Inc.
Last Price:
$17.44
Seasonality Move:
-4.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-24 | 10Q | MXL/MaxLinear, Inc. Quarterly |
| 2024-01-31 | 10K | MXL/MaxLinear, Inc. Annual |
| 2023-10-25 | 10Q | MXL/MaxLinear, Inc. Quarterly |
| 2023-07-27 | 10Q | MXL/MaxLinear, Inc. Quarterly |
| 2023-04-26 | 10Q | MXL/MaxLinear, Inc. Quarterly |
| 2023-02-01 | 10K | MXL/MaxLinear, Inc. Annual |
Receive MXL News And Ratings
See the #1 stock for the next 7 days that we like better than MXL
MXL Financial Statistics
Sales & Book Value
| Annual Sales: | $467.6M |
|---|---|
| Cash Flow: | $6.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.23 |
| Price / Book: | 3.31 |
Profitability
| EPS (TTM): | -1.58240 |
|---|---|
| Net Income (TTM): | $-136.7M |
| Gross Margin: | $240.9M |
| Return on Equity: | -28.31% |
| Return on Assets: | -16.31% |
MaxLinear, Inc. Earnings Forecast
Key MaxLinear, Inc. Financial Ratios
-
The Gross Profit Margin over the past 19 years for MXL is 51.51%.
-
The Selling, General & Administrative Expenses for MXL have been equal to 34.12% of Gross Profit Margin.
-
The Research & Development expenses have been 44.61% of Revenue.
-
The Net Earning history of MXL is -29.23% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
MaxLinear, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | MXL |
| CUSIP: | 57776J |
| Website: | maxlinear.com |
Debt
| Debt-to-Equity Ratio: | 0.32 |
|---|---|
| Current Ratio: | 1.34 |
| Quick Ratio: | 0.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15.22 |
MXL Technical Analysis vs Fundamental Analysis
Sell
34
MaxLinear, Inc. (MXL)
is a Sell
Is MaxLinear, Inc. a Buy or a Sell?
-
MaxLinear, Inc. stock is rated a SellThe current MaxLinear, Inc. [MXL] share price is $17.42. The Score for MXL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.